Obesity & Insulin Resistance for Anesthesia Boards | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Obesity and Insulin Resistance: What Anesthesiologists Must Know [ Medical Education ](https://mdster.com/blog?category=medical-education) Obesity and Insulin Resistance: What Anesthesiologists Must Know ================================================================== A high-yield, clinically applied metabolic walkthrough—adipokines, ectopic fat, and metabolic syndrome—built for the OR and the boards. [ MDster Editorial Team ](https://mdster.com/about) · Feb 07, 2026 · 4 min read · 68 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Perioperative Medicine ](https://mdster.com/blog?tag=perioperative-medicine) [ Anesthesiology ](https://mdster.com/blog?tag=anesthesiology) [ Anesthesiology Boards ](https://mdster.com/blog?tag=anesthesiology-boards) [ Obesity ](https://mdster.com/blog?tag=obesity) [ Insulin Resistance ](https://mdster.com/blog?tag=insulin-resistance) [ Metabolic Syndrome ](https://mdster.com/blog?tag=metabolic-syndrome) Share this article Share this post Your patient rolls into pre-op: BMI 42, “not diabetic,” A1c 5.6%, BP a little high, triglycerides high-normal. Two hours into a laparoscopic case, their glucose is 230 mg/dL and the surgeon is asking why the wound looks edematous already. This is the classic anesthesia trap: you’re staring at **stress hyperglycemia** and **insulin resistance** in real time—without the comfort of a diabetes label. In boards-land and in the OR, obesity-related insulin resistance is less about willpower and more about **where fat is stored** and **what that fat is secreting**. Think of adipose as an endocrine organ that has gotten loud, inflamed, and leaky. The mental model: adipose as an overfilled endocrine organ ---------------------------------------------------------- In uncomplicated energy storage, adipocytes expand, store triglyceride, and stay relatively insulin sensitive. In chronic overnutrition, adipocytes hypertrophy faster than their blood supply can keep up. That local **hypoxia and cellular stress** recruits immune cells (especially macrophages) and shifts adipose tissue toward a pro-inflammatory phenotype. What matters for anesthesia: insulin resistance is a **system-level phenotype**. It amplifies the perioperative stress response (more hyperglycemia for a given catecholamine/cortisol load), tracks with **endothelial dysfunction**, and travels with comorbidities you *do* care about—OSA, NAFLD, hypertension, CAD, HFpEF. Adipokines and inflammation: why insulin signaling gets “jammed” ---------------------------------------------------------------- If you remember one biochemical mechanism, make it this: inflammatory signaling drives **serine phosphorylation** of insulin pathway proteins (IRS-1/2), blunting downstream PI3K/Akt signaling and reducing GLUT4 translocation in muscle and adipose. Clinically, that means higher insulin levels are required for the same glucose disposal—and perioperatively, you see the consequence as hyperglycemia that’s surprisingly stubborn. Obesity shifts the adipokine mix. The board-relevant pattern is: **leptin up (but resistant), adiponectin down, inflammatory cytokines up**. Mediator (source)Obesity trendWhat it does (high-yield)**Leptin** (adipocyte)↑Signals satiety; obesity is a state of **leptin resistance**; also pro-inflammatory/immune-activating.**Adiponectin** (adipocyte)↓Insulin-sensitizing; promotes fatty acid oxidation; anti-inflammatory and vasoprotective. Low levels track with cardiometabolic risk.**TNF-α / IL-6** (adipose macrophages + adipocytes)↑Impairs insulin signaling; promotes lipolysis → ↑ free fatty acids (FFAs) → more insulin resistance.**Resistin, MCP-1** (immune-adipose axis)↑Reinforces immune cell recruitment and inflammatory tone; correlates with insulin resistance. Inflammation isn’t an academic detail—it’s why insulin resistance behaves like a perioperative risk multiplier: - Baseline **pro-thrombotic** and **pro-atherogenic** signaling rides along with the metabolic phenotype. - Endothelial nitric oxide signaling is impaired, contributing to **hypertension** and microvascular dysfunction. - Lipolysis increases circulating FFAs, which worsen hepatic and muscle insulin resistance. Ectopic fat: when storage overflows and organs pay the price ------------------------------------------------------------ Subcutaneous fat is relatively “safe” storage. The problem is **visceral** and **ectopic** fat—fat deposited where it doesn’t belong: - **Liver (NAFLD/MASLD)**: hepatic fat increases gluconeogenesis and VLDL output → hypertriglyceridemia and fasting hyperglycemia. - **Skeletal muscle**: intramyocellular lipid (and lipid intermediates like diacylglycerol/ceramides) interferes with insulin signaling → reduced glucose uptake. - **Pancreas**: fat infiltration stresses β-cells; over time, compensation fails → progression toward type 2 diabetes. - **Heart/perivascular fat**: contributes to diastolic dysfunction, arrhythmogenic substrate, and vascular inflammation. Why this matters to you: ectopic fat is the bridge between “BMI” and **cardiometabolic risk**. Two patients can share the same BMI and have completely different perioperative trajectories depending on visceral/ectopic fat burden. Practical anesthesia consequences: - **NAFLD/MASLD** should make you pause before assuming “normal liver.” Mild disease often has normal AST/ALT; advanced fibrosis is the real anesthetic landmine (coagulopathy, portal HTN physiology, altered drug handling). - Visceral adiposity correlates with **OSA** and **hypoventilation risk**, but it also tracks with **HFpEF**—the patient who desaturates with a small fluid bolus and hates tachycardia. Metabolic syndrome: criteria you should recognize on sight ---------------------------------------------------------- Metabolic syndrome is the exam-friendly clinical packaging of visceral adiposity + insulin resistance + vascular risk. The classic (ATP III/AHA-NHLBI–style) criteria: **any 3 of 5**. ComponentThreshold (typical ATP III cutoffs)Central obesityWaist circumference >102 cm (men) or >88 cm (women) *(ethnicity-specific cutoffs exist)*Triglycerides≥150 mg/dL (or on treatment)HDL<40 mg/dL (men) or <50 mg/dL (women) (or on treatment)Blood pressure≥130/85 mmHg (or on treatment)Fasting glucose≥100 mg/dL (or on treatment) Mechanistically, metabolic syndrome isn’t five random numbers. It’s one loop: 1. Visceral/ectopic fat increases FFAs and inflammatory mediators. 2. Insulin resistance drives hyperinsulinemia. 3. Hyperinsulinemia plus adipose inflammation increases sympathetic tone, renal sodium retention, and RAAS activity → hypertension. 4. Hepatic insulin resistance increases VLDL production and triglycerides; HDL falls. Board pitfall: don’t confuse metabolic syndrome with diabetes. Many patients meet criteria with an A1c still in the “normal” range. Perioperative translation: what changes in your anesthetic plan --------------------------------------------------------------- Insulin resistance shows up when surgical stress turns on counter-regulatory hormones (catecholamines, cortisol, glucagon, GH). In insulin-sensitive patients, endogenous insulin compensates. In insulin-resistant patients, compensation is blunted, and glucose rises—sometimes dramatically. What to do with that information: - **Don’t ignore intraop hyperglycemia** just because the patient “isn’t diabetic.” Persistent glucose elevation is associated with infection risk and worse outcomes, and it’s often a marker of physiologic stress. - **Aim for pragmatic glycemic targets.** In most non-cardiac surgical and ICU contexts, a common evidence-based target is roughly **140–180 mg/dL**, avoiding both severe hyperglycemia and hypoglycemia. - **Plan monitoring proportionate to the case.** A short, low-stress procedure may only need a pre-op glucose in higher-risk patients. Long cases, major abdominal/thoracic surgery, vascular surgery, or steroid use should push you toward scheduled intraop checks and an insulin strategy. - **Treat the physiology, not the number.** If glucose is rising fast, ask why: inadequate analgesia, light anesthesia, infection/sepsis physiology, pressor-heavy hemodynamics, or exogenous dextrose load. Medication context (increasingly common in 2026): many obese, insulin-resistant patients are on GLP-1–based anti-obesity therapy. Those agents can alter gastric emptying and nausea risk in some patients—so coordinate pre-op medication planning with local policy and the prescribing team, and keep aspiration risk thinking sharp. > **Clinical Pearl:** When an “A1c-normal” obese patient runs a glucose of 220–250 mg/dL under anesthesia, assume **insulin resistance + stress response** until proven otherwise—then look for *what’s driving stress* (pain, light plane, infection, catecholamines, steroids) before you just chase insulin. Clinical correlations that show up on exams (and in PACU) --------------------------------------------------------- A few high-yield pairings to keep straight: - **Low adiponectin** is a big hint for insulin resistance and vascular risk (opposite vibe of “protective adipokine”). - **Visceral/ectopic fat** is more predictive than BMI for cardiometabolic complications—think NAFLD/MASLD, hypertriglyceridemia, HFpEF. - Metabolic syndrome is a **risk cluster**: if you see it, you should expect OSA, difficult BP control, and perioperative hyperglycemia even without established diabetes. Key Takeaways ------------- - Obesity-related insulin resistance is driven by **adipose inflammation**, not just excess calories. - The adipokine pattern to remember: **leptin ↑ (resistance), adiponectin ↓, TNF-α/IL-6 ↑** → impaired insulin signaling. - **Ectopic fat** (liver, muscle, pancreas, heart) is the engine of cardiometabolic risk; BMI alone is a blunt tool. - **Metabolic syndrome** (3 of 5: waist, TG, HDL, BP, fasting glucose) is a board favorite and a real perioperative risk flag. - Intraop hyperglycemia in an “nondiabetic” obese patient is often **stress + insulin resistance**—monitor appropriately and manage with safe, moderate glycemic targets while addressing the stressors. Conclusion ---------- If you treat obesity like a number on the scale, you’ll miss the physiology that matters in anesthesia: inflamed adipose tissue, ectopic fat burden, and the insulin-resistant stress response. Learn the adipokine story, recognize metabolic syndrome instantly, and you’ll predict who’s going to run hypertensive, hyperglycemic, and complication-prone—then you can build an anesthetic plan that’s proactive instead of reactive. Study pathway Build momentum in Anesthesiology with focused, exam‑style practice -------------------------------------------------------------------- - Airway, ventilation, and crisis drills - High‑yield anesthesia pharmacology made practical - Track weak topics and improve faster Free 5-day trial No credit card required. [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() Related Posts ------------- [ ![Fellowship of the Hong Kong College of Anaesthesiologists (Intermediate Fellowship Examinations): Study Tips That Work](https://mdster.com/storage/blog/images/fellowship-of-the-hong-kong-college-of-anaesthesiologists-intermediate-fellowship-examinat.jpg) Study Tips ### Fellowship of the Hong Kong College of Anaesthesiologists (Intermediate Fellowship Examinations): Study Tips That Work Preparing for the HKCA Intermediate Fellowship Exam? Use this focused study plan to tackle physiology, pharmacology, statistics, SAQs, and viva practice efficiently. 6 min read 0 comments ](https://mdster.com/blog/fellowship-of-the-hong-kong-college-of-anaesthesiologists-intermediate-fellowship-examinat) [ ![Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap](https://mdster.com/storage/blog/images/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap.jpg) Medical Education ### Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap A focused Family Medicine review of anxiety, depression, and dyspnea in severe COPD/asthma overlap, with safer prescribing, breathing retraining, and board-style pitfalls. 6 min read 0 comments ](https://mdster.com/blog/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap) [ ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg) Medical Education ### IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy A focused Internal Medicine review of IBS diagnosis: how to use Rome IV concepts, separate IBS-C from IBS-D and mixed IBS, and decide when colonoscopy is truly indicated. 7 min read 0 comments ](https://mdster.com/blog/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept